• LAST PRICE
    2.3100
  • TODAY'S CHANGE (%)
    Trending Up0.0500 (2.2124%)
  • Bid / Lots
    2.1900/ 67
  • Ask / Lots
    2.3300/ 87
  • Open / Previous Close
    2.2700 / 2.2600
  • Day Range
    Low 2.2700
    High 2.3550
  • 52 Week Range
    Low 2.0000
    High 3.6700
  • Volume
    126,024
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 2.26
TimeVolumeORMP
09:32 ET34622.299
09:33 ET30002.3
09:35 ET60002.2915
09:37 ET52552.3001
09:53 ET1002.3175
10:04 ET1002.31
10:06 ET29002.315
10:09 ET53452.31
10:11 ET1002.31
10:13 ET9002.31
10:15 ET75352.3
10:18 ET7302.3
10:26 ET55002.3
10:29 ET3002.305
10:33 ET211052.3
10:36 ET1002.305
10:38 ET1002.3
10:44 ET1002.3
10:45 ET36002.31
10:47 ET1002.31
10:49 ET4042.3005
10:58 ET5002.305
11:00 ET2382.305
11:05 ET9132.31
11:34 ET7062.315
11:50 ET2382.315
12:06 ET2072.313537
12:08 ET31102.33
12:21 ET22612.34
12:26 ET20002.3494
12:30 ET19842.3407
12:32 ET40002.34
12:42 ET27002.3405
12:50 ET10172.3403
12:57 ET46022.35
01:36 ET2002.35346
01:40 ET10002.355
01:44 ET22342.351
01:45 ET22002.3501
01:47 ET79412.35
01:54 ET1002.34
02:00 ET6402.3403
02:05 ET11002.34
02:09 ET42002.34
02:12 ET4002.34
02:59 ET13512.345
03:14 ET12802.35
03:17 ET2002.3451
03:19 ET11002.345
03:50 ET21302.34
03:53 ET4272.33
04:00 ET2942.31
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesORMP
Oramed Pharmaceuticals Inc
93.1M
23.1x
---
United StatesMNOV
MediciNova Inc
98.1M
-9.3x
---
United StatesMIST
Milestone Pharmaceuticals Inc
98.5M
-2.3x
---
United StatesANVS
Annovis Bio Inc
93.7M
-1.8x
---
United StatesGNTA
Genenta Science SPA
87.8M
-9.4x
---
United StatesRGLS
Regulus Therapeutics Inc
91.7M
-1.3x
---
As of 2024-11-22

Company Information

Oramed Pharmaceuticals Inc. is a pharmaceutical company engaged in the research and development of pharmaceutical solutions with a technology platform. The Company has developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its Protein Oral Delivery (POD) technology is designed to protect drug integrity and increase absorption. Its pipeline includes ORMD-0801 (Oral Insulin) Diabetes, ORMD-0801 (Oral Insulin) NASH, and ORMD 0901 (Oral GLP-1). Its oral insulin (ORMD-0801) has the potential to create a new paradigm in the treatment of diabetes through oral delivery of insulin at an earlier stage of treatment. Its oral insulin capsule (ORMD-0801) has shown a reduction of liver fat content in early clinical trials. It is also developing an oral Glucagon-like peptide-1 (GLP-1) analog capsule (ORMD-0901), which is an incretin hormone that stimulates the secretion of insulin from the pancreas.

Contact Information

Headquarters
1185 AVENUE OF THE AMERICAS, 3RD FLOORNEW YORK, NY, United States 10036
Phone
646-844-1164
Fax
845-818-3588

Executives

Chairman of the Board, President, Chief Executive Officer
Nadav Kidron
Chief Financial Officer, Treasurer, Company Secretary
Avraham Gabay
Chief Operating and Business Officer
Joshua Hexter
Chief Scientific Officer, Director
Miriam Kidron
Independent Director
Daniel Aghion

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$93.1M
Revenue (TTM)
$0.00
Shares Outstanding
40.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.70
EPS
$0.10
Book Value
$4.06
P/E Ratio
23.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
20.2x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.